The evolution in registration of clinical trials: A chronicle of the historical calls and current initiatives promoting transparency

European Journal of Clinical Pharmacology

Volumn 71, Issue 10, 2015, Pages 1159-1164

  Pansieri, Claudia ^a   Pandolfini, Chiara ^a   Bonati, Maurizio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Clinical trials as topic legislation and jurisprudence; Government regulation; Publication bias; Registries

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; OSELTAMIVIR; ROFECOXIB; ZANAMIVIR;

CLINICAL RESEARCH; CLINICAL STUDY; CLINICAL TRIAL (TOPIC); CONSULTATION; DRUG INDUSTRY; HEALTH CARE POLICY; HUMAN; INVESTMENT; NATIONAL HEALTH ORGANIZATION; PATIENT CARE; PRIORITY JOURNAL; PROFESSIONAL STANDARD; PUBLICATION; REGISTRATION; REVIEW; WORLD HEALTH ORGANIZATION; HISTORY; INTERPERSONAL COMMUNICATION; PEER REVIEW; RESEARCH ETHICS; STANDARDS; UNITED STATES;

CLINICAL TRIALS AS TOPIC; DISCLOSURE; ETHICS, RESEARCH; HISTORY, 20TH CENTURY; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); PEER REVIEW; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 84941416626     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-015-1897-9     Document Type: Review

References (59)

1. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM (2012) Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 344:d7292
2. Hart B, Lundh A, Bero L (2012) Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ 344:d7202
3. Simundic AM (2013) Bias in research. Biochem Med (Zagreb) 23:12-15
4. Armstrong R, Hall BJ, Doyle J, Waters E (2011) Cochrane update. 'scoping the scope' of a cochrane review. J Public Health (Oxf) 33:147-150
5. Huser V, Cimino JJ (2013) Evaluating adherence to the International Committee of Medical Journal Editors' policy of mandatory, timely clinical trial registration. J Am Med Inform Assoc 20:e169-e174. doi: 10.1136/amiajnl-2012-001501
6. Miller JE (2013) How a clinical trial registry became a symbol of misinformation. Hastings Cent Rep 43:11-12
7. Simes RJ (1986) Publication bias: the case for an international registry of clinical trials. J Clin Oncol 4:1529-1541
8. Gotzsche PC (2011) Why we need easy access to all data from all clinical trials and how to accomplish it. Trials 12:249
9. Chalmers I (1990) Underreporting research is scientific misconduct. JAMA 263:1405-1408
10. Godlee F (2013) Timely publication of all trial results may mean less overtreatment. BMJ 346:f159
11. Liberati A (2011) Need to realign patient-oriented and commercial and academic research. Lancet 378:1777-1778
12. Viergever RF, Terry RF, Karam G (2013) Use of data from registered clinical trials to identify gaps in health research and development. Bull WorldHealth Organ 91:416-425C
13. Loder E, Tovey D, Godlee F (2014) The Tamiflu trials. BMJ 348:g2630
14. Appell D (2005) Maine law requires drug companies to provide clinical trial data. J Natl Cancer Inst 97:1246
15. Krleza-Jeric K, Chan AW, Dickersin K, Sim I, Grimshaw J, Gluud C (2005) Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1). BMJ 330:956-958
16. Herxheimer A (2004) Open access to industry's clinically relevant data. BMJ 329:64-65
17. Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases. [Internet] 2014 [Cited 2009 Nov 9] Available from: http://www.ifpma.org/fileadmin/content/Ethics/Clinical-Trials/Nov2009-Joint-Position-CT-Data-Disclosure-registries-and-databases.pdf (Accessed Dec 2014)
18. Joint Position on the Publication of Clinical Trial Results in the Scientific Literature. Available from: http://www.ifpma.org/fileadmin/content/Ethics/Clinical-Trials/June2010-Joint-Position-CT-Data-Publication-scientific
19. Viergever RF, Ghersi D (2011) The quality of registration of clinical trials. PLoS One 6:e14701
20. Viergever RF, Karam G, Reis A, Ghersi D (2014) The quality of registration of clinical trials: still a problem. PLoS One 9:e84727
21. Prayle AP, Hurley MN, Smyth AR (2012) Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study. BMJ 344:d7373
22. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM (2009) Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med 6:e1000144
23. Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM (2012) Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ 344:d7292
24. Logvinov I (2014) Clinical trials transparency and the Trial and Experimental Studies Transparency (TEST) act. Contemp Clin Trials 37:219-224
25. Torjesen I (2014) European Ombudsman ramps up action against European Medicines Agency over data transparency plans. BMJ 348:g3733
26. Eu Trial results: Modalities and timing of posting. Available from https://eudract.ema.europa.eu/docs/guidance/Trial%20results-Modalities%20and%20timing%20of%20posting.pdf (Accessed Dec 2014)
27. Posting of clinical trial summary results in European Clinical Trials Database (EudraCT). http://www.ema.europa.eu/ema/index.jsp?curl;=;pages/news-and-events/news/2014/06/news-detail-002127.jsp∣=;WC0b01ac058004d5c1%29. Accessed Dec 2014
28. Zarin DA, Tse T, Sheehan J (2015) The proposed rule for U.S. clinical trial registration and results submission. N Engl J Med 372:174-180
29. Groves T (2014) Big strides in Europe towards clinical trial transparency. BMJ 349:g6276
30. Draft proposal for an addendum, on transparency, to the "Functional specifications for the EU portal and EU database. Available from: http://www.ema.europa.eu/docs/en-GB/document-library/Other/2015/01/WC500180618.pdf (2015)
31. The ENCePP Code of Conduct. Available at: http://www.encepp.eu/code-of-conduct/documents/ENCePPCodeofConduct-Rev3.pdf (Accessed Dec 2014)
32. Banzi R, Bertele V, Garattini S (2014) EMA's transparency seems to be opaque. Lancet 384:1847
33. Hudson KL, Collins FS (2015) Sharing and reporting the results of clinical trials. JAMA 313:355-356
34. NIH Policy on dissemination. Available at: http://grants.nih.gov/grants/guide/noticefiles/NOT-OD-15-019.html. (Accessed Dec 2014)
35. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P (2009) Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 302:977-984
36. Wieseler B, Kerekes MF, Vervoelgyi V, McGauran N, Kaiser T (2012) Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications. BMJ 344:d8141
37. Vioxx withdrawal. Available at: http://www.pbm.va.gov/vacenterformedicationsafety/vioxx/DearHealthcareProfessional.pdf (Accessed Jan 2015)
38. Doshi P, Jefferson T, Del MC (2012) The imperative to share clinical study reports: recommendations from the Tamiflu experience. PLoS Med 9:e1001201
39. Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ (2014) Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 4:CD008965
40. Eichler HG, Abadie E, Breckenridge A, Leufkens H, Rasi G (2012) Open clinical trial data for all? a view from regulators. PLoS Med 9:e1001202
41. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637-641
42. Dwan K, Altman DG, Cresswell L, Blundell M, Gamble CL, Williamson PR (2011) Comparison of protocols and registry entries to published reports for randomised controlled trials. Cochrane Database Syst Rev MR000031
43. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG (2004) Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 291:2457-2465
44. Jones CW, Handler L, Crowell KE, Keil LG, Weaver MA, Platts-Mills TF (2013) Non-publication of large randomized clinical trials: cross sectional analysis. BMJ 347:f6104
45. Ramagopalan S, Skingsley AP, Handunnetthi L, Klingel M, Magnus D, Pakpoor J, Goldacre B (2014) Prevalence of primary outcome changes in clinical trials registered on ClinicalTrials.gov: a cross-sectional study. F1000Res 3:77
46. Anderson ML, Chiswell K, Peterson ED, Tasneem A, Topping J, Califf RM (2015) Compliance with results reporting at ClinicalTrials.gov. N Engl J Med 372:1031-1039
47. Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K (2009) Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Database Syst Rev MR000006
48. Bourgeois FT, Murthy S, Mandl KD (2010) Outcome reporting among drug trials registered in ClinicalTrials.gov. Ann Intern Med 153:158-166
49. Chan AW, Song F, Vickers A, Jefferson T, Dickersin K, Gotzsche PC, Krumholz HM, Ghersi D, van der Worp HB (2014) Increasing value and reducing waste: addressing inaccessible research. Lancet 383:257-266
50. Moorthy VS, Karam G, Vannice KS, Kieny MP (2015) Rationale for WHO's new position calling for prompt reporting and public disclosure of interventional clinical trial results. PLoS Med 12:e1001819
51. Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hrobjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D (2013) SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ 346:e7586
52. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D (2013) SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 158:200-207
53. Chalmers I (2013) Health research authority's great leap forward on UK trial registration. BMJ 347:f5776
54. Riveros C, Dechartres A, Perrodeau E, Haneef R, Boutron I, Ravaud P (2013) Timing and completeness of trial results posted at ClinicalTrials.gov and Published in Journals. PLoS Med 10:e1001566
55. Ross JS, Mocanu M, Lampropulos JF, Tse T, Krumholz HM (2013) Time to publication among completed clinical trials. JAMA Intern Med 173:825-828
56. Guideline for industry: structure and content of clinical study reports. (ICH E3) (2013) FDA 30-3-2015
57. Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 340:c332
58. Mitka M (2015) Clinical trial data: share and share alike? JAMA 313:881-882
59. Pandolfini C, Garattini S, Bonati M (2013) Clinical trial registries: from an omen to a common and disclosed practice. Eur J Clin Pharmacol 69:1725-1726